Cargando…

Publisher Correction: Necroptosis mediates myofibre death in dystrophin-deficient mice

Detalles Bibliográficos
Autores principales:	Morgan, Jennifer E., Prola, Alexandre, Mariot, Virginie, Pini, Veronica, Meng, Jinhong, Hourde, Christophe, Dumonceaux, Julie, Conti, Francesco, Relaix, Frederic, Authier, Francois-Jerôme, Tiret, Laurent, Muntoni, Francesco, Bencze, Maximilien
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Publisher Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6168580/ https://www.ncbi.nlm.nih.gov/pubmed/30279414 http://dx.doi.org/10.1038/s41467-018-06636-w

Ejemplares similares

Necroptosis mediates myofibre death in dystrophin-deficient mice
por: Morgan, Jennifer E., et al.
Publicado: (2018)

Transiently expressed CRISPR/Cas9 induces wild-type dystrophin in vitro in DMD patient myoblasts carrying duplications
por: Pini, Veronica, et al.
Publicado: (2022)

RIPK3‐mediated cell death is involved in DUX4‐mediated toxicity in facioscapulohumeral dystrophy
por: Mariot, Virginie, et al.
Publicado: (2021)

Mechanisms of Myofibre Death in Muscular Dystrophies: The Emergence of the Regulated Forms of Necrosis in Myology
por: Bencze, Maximilien
Publicado: (2022)

A Deoxyribonucleic Acid Decoy Trapping DUX4 for the Treatment of Facioscapulohumeral Muscular Dystrophy
por: Mariot, Virginie, et al.
Publicado: (2020)

Global gene expression in muscle from fasted/refed trout reveals up-regulation of genes promoting myofibre hypertrophy but not myofibre production
por: Rescan, Pierre-Yves, et al.
Publicado: (2017)

Gene Editing to Tackle Facioscapulohumeral Muscular Dystrophy
por: Mariot, Virginie, et al.
Publicado: (2022)

Downregulation of myostatin pathway in neuromuscular diseases may explain challenges of anti-myostatin therapeutic approaches
por: Mariot, Virginie, et al.
Publicado: (2017)

Myostatin Is a Quantifiable Biomarker for Monitoring Pharmaco-gene Therapy in Duchenne Muscular Dystrophy
por: Mariot, Virginie, et al.
Publicado: (2020)

Myostatin inhibition in combination with antisense oligonucleotide therapy improves outcomes in spinal muscular atrophy
por: Zhou, Haiyan, et al.
Publicado: (2020)

The effect of the muscle environment on the regenerative capacity of human skeletal muscle stem cells
por: Meng, Jinhong, et al.
Publicado: (2015)

Optimized lentiviral vector to restore full-length dystrophin via a cell-mediated approach in a mouse model of Duchenne muscular dystrophy
por: Meng, Jinhong, et al.
Publicado: (2022)

Publisher Correction: COVID-19 antibodies on trial
por: DeFrancesco, Laura
Publicado: (2021)

Publisher Correction: Mergeable nervous systems for robots
por: Mathews, Nithin, et al.
Publicado: (2017)

Lentiviral vectors can be used for full-length dystrophin gene therapy
por: Counsell, John R., et al.
Publicado: (2017)

Lentiviral vectors can be used for full-length dystrophin gene therapy
por: Counsell, John R., et al.
Publicado: (2017)

A myofibre model for the study of uterine excitation-contraction dynamics
por: Goldsztejn, Uri, et al.
Publicado: (2020)

Publisher Correction: The effect of attention and working memory on the estimation of elapsed time
por: Polti, Ignacio, et al.
Publicado: (2019)

Targeting the Polyadenylation Signal of Pre-mRNA: A New Gene Silencing Approach for Facioscapulohumeral Dystrophy
por: Marsollier, Anne-Charlotte, et al.
Publicado: (2018)

Therapeutic Strategies Targeting DUX4 in FSHD
por: Le Gall, Laura, et al.
Publicado: (2020)

DUX4 Expression in FSHD Muscles: Focus on Its mRNA Regulation
por: Sidlauskaite, Eva, et al.
Publicado: (2020)

Erratum: Lentiviral vectors can be used for full-length dystrophin gene therapy
por: Counsell, John R., et al.
Publicado: (2017)

Multiple exon skipping strategies to by-pass dystrophin mutations
por: Adkin, Carl F., et al.
Publicado: (2012)

Publisher Correction: Orthogonal regulation of DNA nanostructure self-assembly and disassembly using antibodies
por: Ranallo, Simona, et al.
Publicado: (2020)

Effects of Mini-Dystrophin on Dystrophin-Deficient, Human Skeletal Muscle-Derived Cells
por: Meng, Jinhong, et al.
Publicado: (2020)

Publisher Correction: Publisher correction for multiple articles
Publicado: (2022)

Publisher Correction: Identification of new DNA-associated proteins from Waddlia chondrophila
por: de Barsy, Marie, et al.
Publicado: (2019)

Generation of two genomic-integration-free DMD iPSC lines with mutations affecting all dystrophin isoforms and potentially amenable to exon-skipping
por: Ferrari, Giulia, et al.
Publicado: (2020)

Publisher Correction: Rapid human-driven undermining of atoll island capacity to adjust to ocean climate-related pressures
por: Duvat, Virginie K. E., et al.
Publicado: (2019)

Publisher Correction: Real-space observation of ergodicity transitions in artificial spin ice
por: Saccone, Michael, et al.
Publicado: (2023)

Antisense suppression of donor splice site mutations in the dystrophin gene transcript
por: Fletcher, Sue, et al.
Publicado: (2013)

Genetic Evidence That Captured Retroviral Envelope syncytins Contribute to Myoblast Fusion and Muscle Sexual Dimorphism in Mice
por: Redelsperger, François, et al.
Publicado: (2016)

Autologous skeletal muscle derived cells expressing a novel functional dystrophin provide a potential therapy for Duchenne Muscular Dystrophy
por: Meng, Jinhong, et al.
Publicado: (2016)

Gene Editing Targeting the DUX4 Polyadenylation Signal: A Therapy for FSHD?
por: Joubert, Romains, et al.
Publicado: (2020)

Publisher’s Note
Publicado: (2019)

PUBLISHER’S NOTE
Publicado: (2019)

Publisher’s note
Publicado: (2020)

Publisher's Note
Publicado: (2018)

Publisher's Note
Publicado: (2018)

Publisher's Note
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nbmfs79t0l7ljspthp3nbp4p1v